Ignite Creation Date:
2024-05-06 @ 10:26 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03256721
Status:
TERMINATED
Last Update Posted:
2021-02-08
First Post:
2017-08-16
Brief Title:
Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC
Sponsor:
Organization:
Fuzhou General Hospital